Cargando…

The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management.

Somatostatin receptors are present in the normal adrenal cortex and medulla. These receptors are also expressed by tumors that cause Cushing's syndrome and by pheochromocytomas. Somatostatin analogues such as octreotide have been developed to target somatostatin receptors for diagnostic and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kennedy, J. W., Dluhy, R. G.
Formato: Texto
Lenguaje:English
Publicado: Yale Journal of Biology and Medicine 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2589262/
https://www.ncbi.nlm.nih.gov/pubmed/9825485
_version_ 1782161084489138176
author Kennedy, J. W.
Dluhy, R. G.
author_facet Kennedy, J. W.
Dluhy, R. G.
author_sort Kennedy, J. W.
collection PubMed
description Somatostatin receptors are present in the normal adrenal cortex and medulla. These receptors are also expressed by tumors that cause Cushing's syndrome and by pheochromocytomas. Somatostatin analogues such as octreotide have been developed to target somatostatin receptors for diagnostic and therapeutic purposes. This article reviews the current knowledge of the biology of somatostatin receptors in the normal adrenal gland and in adrenal tumors and defines the current role of the somatostatin receptor in the diagnosis, staging and management of Cushing's syndrome and pheochromocytomas.
format Text
id pubmed-2589262
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher Yale Journal of Biology and Medicine
record_format MEDLINE/PubMed
spelling pubmed-25892622008-12-01 The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management. Kennedy, J. W. Dluhy, R. G. Yale J Biol Med Research Article Somatostatin receptors are present in the normal adrenal cortex and medulla. These receptors are also expressed by tumors that cause Cushing's syndrome and by pheochromocytomas. Somatostatin analogues such as octreotide have been developed to target somatostatin receptors for diagnostic and therapeutic purposes. This article reviews the current knowledge of the biology of somatostatin receptors in the normal adrenal gland and in adrenal tumors and defines the current role of the somatostatin receptor in the diagnosis, staging and management of Cushing's syndrome and pheochromocytomas. Yale Journal of Biology and Medicine 1997 /pmc/articles/PMC2589262/ /pubmed/9825485 Text en
spellingShingle Research Article
Kennedy, J. W.
Dluhy, R. G.
The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management.
title The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management.
title_full The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management.
title_fullStr The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management.
title_full_unstemmed The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management.
title_short The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management.
title_sort biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2589262/
https://www.ncbi.nlm.nih.gov/pubmed/9825485
work_keys_str_mv AT kennedyjw thebiologyandclinicalrelevanceofsomatostatinreceptorscintigraphyinadrenaltumormanagement
AT dluhyrg thebiologyandclinicalrelevanceofsomatostatinreceptorscintigraphyinadrenaltumormanagement
AT kennedyjw biologyandclinicalrelevanceofsomatostatinreceptorscintigraphyinadrenaltumormanagement
AT dluhyrg biologyandclinicalrelevanceofsomatostatinreceptorscintigraphyinadrenaltumormanagement